Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and Collaborations

Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S141-S146. doi: 10.1093/cid/ciac522.

Abstract

The US Centers for Disease Control and Prevention (CDC); state, tribal, local, and territorial health departments; other US government departments and agencies; the private sector; and international partners have engaged in a real-time public health response to the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccination, variants, and vigilance were themes that arose in the second year of pandemic response in the United States. The findings included in this supplement emerged from these themes and represent some of the many collaborative efforts to improve public health knowledge and action to reduce transmission, infection, and disease severity.

Keywords: CDC; COVID-19; SARS-CoV-2‌; public health; vaccines.

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Pandemics / prevention & control
  • Public Health
  • SARS-CoV-2
  • United States / epidemiology
  • Vaccines*

Substances

  • Vaccines